Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0E9CK
|
|||
| Drug Name |
Aryl alkanolamine derivative 1
|
|||
| Synonyms |
PMID28051882-Compound-7
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
UNIVERSITA' DEGLI STUDI DI PAVIA
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H27NO
|
|||
| Canonical SMILES |
C1CCN(CC1)CCC(CO)C2=CC=C(C=C2)C3=CC=CC=C3
|
|||
| InChI |
1S/C21H27NO/c23-17-21(13-16-22-14-5-2-6-15-22)20-11-9-19(10-12-20)18-7-3-1-4-8-18/h1,3-4,7-12,21,23H,2,5-6,13-17H2
|
|||
| InChIKey |
DUVDSTKOGVWACP-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Opioid receptor sigma 1 (OPRS1) | Target Info | Antagonist | [1] |
| Target's Patent Info | Opioid receptor sigma 1 (OPRS1) | Target's Patent Info | [1] | |
| WikiPathways | miR-targeted genes in squamous cell - TarBase | |||
| miR-targeted genes in lymphocytes - TarBase | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Are sigma modulators an effective opportunity for cancer treatment A patent overview (1996-2016).Expert Opin Ther Pat. 2017 May;27(5):565-578. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.